Nicaragua

Plant-use surveys and clinical evidence gaps

Evidence at a glance

Scope: Botanical traditions and human research relevant to Nicaragua. Evidence types: Ethnobotanical reports, observational studies, clinical trials or safety assessments where cited. Cancer control: No demonstrated cure from the traditional-use records summarized here. Limitation: Selective source review, not a systematic review.

Miskitu plant knowledge

Ethnobotanical observation · not efficacy testing. Coe and Anderson’s 1997 ethnobotanical report recorded uses of 353 species over two years of fieldwork, including 310 medicinal species. Documentation of an ailment, preparation or local name is not proof of a clinically meaningful response, and a historical field survey cannot represent every contemporary Miskitu practice.

Ulwa knowledge and cross-community similarities

Published ethnobotany · no controlled treatment outcomes. An Ulwa ethnobotany study documented 225 useful plant species, including 187 used medicinally, and described overlap with Miskitu records. The authors recorded plant parts, preparations and intended uses. None of those catalog counts are trials, and shared species do not mean identical cultural meaning or preparation.

Household use in Managua

Household survey · prevalence, not proof of benefit. A survey of a Managua neighborhood found herbal remedies used in 78% of sampled households. That is an important insight for conversations about access, affordability and complementary treatment, but it cannot measure clinical effectiveness or drug interaction rates.

Medicine, identity and clinical care

Historical social-science research · no efficacy claim. A 1995 study of Nicaragua’s Atlantic Coast explores how herbal, spiritual and biomedical care coexist and vary among communities. We should ask about access to appropriate medical care without portraying traditional healing as a substitute for cancer treatment.

Clinical interpretation and safety

Documented traditional use does not establish treatment efficacy. Extracts, infusions, foods, and isolated compounds are different interventions. Laboratory cytotoxicity is not clinical tumor control. Review supplements and interactions with the treating team; do not substitute unverified products for established cancer care.

Sources: Primary references linked in the evidence sections above. Last chapter edit: October 18, 2026. Evidence scope: selective, not exhaustive. Evidence Explorer · Methods.